Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
11.1M
-
Shares change
-
+177K
-
Total reported value, excl. options
-
$313M
-
Value change
-
+$4.92M
-
Put/Call ratio
-
0.88
-
Number of buys
-
38
-
Number of sells
-
-37
-
Price
-
$28.22
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q3 2018
100 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q3 2018.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.1M shares
of 100M outstanding shares and own 11.05% of the company stock.
Largest 10 shareholders include FMR LLC (4.24M shares), Capital World Investors (875K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (800K shares), ARMISTICE CAPITAL, LLC (600K shares), BlackRock Inc. (505K shares), MORGAN STANLEY (481K shares), SPHERA FUNDS MANAGEMENT LTD. (448K shares), ARK Investment Management LLC (394K shares), Tekla Capital Management LLC (279K shares), and MACQUARIE GROUP LTD (191K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.